Evidence map›Paper›PMID 24013374›Full record

ArticleInternational journal of molecular sciences2013

Bicistronic gene transfer tools for delivery of miRNAs and protein coding sequences.

Michelle L Stoller, Henry C Chang, Donna M Fekete

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Molecular therapy. Nucleic acids · 2024
    Article
  2. Article
  3. Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead.Pflugers Archiv : European journal of physiology · 2016
    Review
  4. Article
  5. Editorial on the Special Issue: Regulation by non-coding RNAs.International journal of molecular sciences · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michelle L StollerDepartment of Biological Sciences, Purdue University, 915 W State St, West Lafayette, IN 47907-1392, USA. dfekete@purdue.edu.
Henry C Chang
Donna M Fekete
Purdue University West Lafayette · US

Funding

DEVELOPMENT STUDIES OF THE INNER EARR01DC002756 · NIDCD · PURDUE UNIVERSITY WEST LAFAYETTE · PI FEKETE, DONNA M · 1995 to 2019
$6.8M
Gene Transfer Tools for Delivery and Investigation of Inner Ear MicroRNAsF31DC011687 · NIDCD · PURDUE UNIVERSITY · PI STOLLER, MICHELLE LYNN · 2011 to 2014
$124k
NIDCD NIH HHS 1F31DC011687NIDCD NIH HHS F31 DC011687NIDCD NIH HHS R01 DC002756NIDCD NIH HHS R01DC002756
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are a category of small RNAs that modulate levels of proteins via post-transcriptional inhibition. Currently, a standard strategy to overexpress miRNAs is as mature miRNA duplexes, although this method is cumbersome if multiple miRNAs need to be delivered. Many of these miRNAs are found within introns and processed through the RNA polymerase II pathway. We have designed a vector to exploit this naturally-occurring intronic pathway to deliver the three members of the sensory-specific miR-183 family from an artificial intron. In one version of the vector, the downstream exon encodes the reporter (GFP) while another version encodes a fusion protein created between the transcription factor Atoh1 and the hemaglutinin epitope, to distinguish it from endogenous Atoh1. In vitro analysis shows that the miRNAs contained within the artificial intron are processed and bind to their targets with specificity. The genes downstream are successfully translated into protein and identifiable through immunofluorescence. More importantly, Atoh1 is proven functional through in vitro assays. These results suggest that this cassette allows expression of miRNAs and proteins simultaneously, which provides the opportunity for joint delivery of specific translational repressors (miRNA) and possibly transcriptional activators (transcription factors). This ability is attractive for future gene therapy use.

Indexed as

Basic Helix-Loop-Helix ProteinsCell LineHumansIntronsMicroRNAsPlasmidsATOH1 protein, humanBasic Helix-Loop-Helix ProteinsMicroRNAsMIRN183 microRNA, human

Identifiers

PMID24013374
PMCPMC3794778
OpenAlexW4234384026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.